Koers Gongwin Biopharm Holdings Co., Ltd.
Aandelen
6617
KYG409471060
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
181,5 TWD | -0,82% | -1,36% | -1,63% |
Omzet 2022 | 1,14 mln. 35,08K 32,77K | Omzet 2023 | 18,92 mln. 581K 542K | Marktkapitalisatie | 20,91 mld. 642 mln. 600 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -254 mln. -7,8 mln. -7,28 mln. | Nettowinst (verlies) 2023 | -101 mln. -3,1 mln. -2,9 mln. | EV/omzet 2022 | 30.768 x |
Nettoliquiditeiten 2022 | 964 mln. 29,59 mln. 27,64 mln. | Nettoliquiditeiten 2023 | 865 mln. 26,55 mln. 24,8 mln. | EV/omzet 2023 | 1.060 x |
K/w-verhouding 2022 |
-140
x | K/w-verhouding 2023 |
-207
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
1 dag | -0,82% | ||
1 week | -1,36% | ||
Lopende maand | -5,47% | ||
1 maand | -3,20% | ||
3 maanden | +6,45% | ||
6 maanden | +6,76% | ||
Lopend jaar | -1,63% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mao Yuan Lin
CEO | Chief Executive Officer | - | 01-05-14 |
Wei Nan Hu
DFI | Director of Finance/CFO | - | 01-06-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lieh Lin Chan
BRD | Director/Board Member | - | 04-12-18 |
Chih Tung Yang
BRD | Director/Board Member | - | 28-01-16 |
Lester John Wu
CHM | Chairman | - | 28-01-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 181,5 | -0,82% | 71 542 |
25-04-24 | 183 | 0,00% | 39 102 |
24-04-24 | 183 | +0,27% | 50 873 |
23-04-24 | 182,5 | +0,27% | 60 513 |
22-04-24 | 182 | -1,09% | 65 511 |
slotkoers Taipei Exchange, 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-1,63% | 631 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |